Financials
Income statement
Fiscal date | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
---|---|---|---|---|
Total reported revenue | 21.2B | 22.0B | 23.3B | 23.2B |
Cost of revenue | 15.2B | 15.5B | 16.6B | 16.9B |
Gross profit | 6.0B | 6.5B | 6.7B | 6.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.6B | 1.3B | 1.5B |
Non operating interest income | ||||
Income | 2M | 0 | 0 | 1M |
Expense | 47M | 48M | 53M | 48M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 1.6B | 1.2B | 1.5B |
Tax provision | 486M | 618M | 469M | 647M |
Net income | 786M | 940M | 716M | 882M |
Basic EPS | — | 18.7 | — | — |
Diluted EPS | — | 18.7 | — | — |
Basic average shares | — | 49.4M | — | — |
Diluted average shares | — | 49.4M | — | — |
EBITDA | 1.3B | 1.6B | 1.4B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -17M | -19M | -29M | -38M |
Preferred stock dividends | 0 | 0 | 0 | 0 |